|
| 35797139 | Experts Opinion: OCTA vs. FFA/ICG in Uveitis - Which Will Survive? | Ocul Immunol Inflamm | 2023 |
| 33416427 | Tuberculous Scleritis and Multidrug Resistance. | Ocul Immunol Inflamm | 2022 |
| 35442874 | Subretinal Fibrosis in Uveitis. | Ocul Immunol Inflamm | 2022 |
| 35404757 | COVID-19 Vaccination and Uveitis: Epidemiology, Clinical Features and Visual Prognosis. | Ocul Immunol Inflamm | 2022 |
| 35901540 | Imaging Ocular Toxoplasmosis. | Ocul Immunol Inflamm | 2022 |
| 35929658 | S2k guideline: Rosacea. | J Dtsch Dermatol Ges | 2022 |
| 36227701 | Ocular Complications Following COVID-19 Vaccination - Coincidence, Correlation, or Causation? | Ocul Immunol Inflamm | 2022 |
| 33793375 | Mesalazine Suppresses Proinflammatory Cytokines in Patients with Acute Anterior Uveitis Independently of HLA-B27. | Ocul Immunol Inflamm | 2022 |
| 33596386 | Drug-induced Sarcoid Uveitis with Biologics. | Ocul Immunol Inflamm | 2022 |
| 33847216 | Occlusive Retinal Vasculitis Following Intravitreal Drug Delivery. | Ocul Immunol Inflamm | 2022 |
| 33617392 | Epidemiology of Viral Induced Anterior Uveitis. | Ocul Immunol Inflamm | 2022 |
| 35226588 | Rosacea and Dry Eye Disease. | Ocul Immunol Inflamm | 2022 |
| 35286230 | A Note from the Editors. | Ocul Immunol Inflamm | 2022 |
| 35286229 | Hypervirulent, Multidrug Resistant <i>Klebsiella pneumoniae</i> - Emergence of a Superbug of Concern for Eye Care Providers. | Ocul Immunol Inflamm | 2022 |
| 32532764 | COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs. | Br J Ophthalmol | 2021 |
| 33635176 | Editorial. | Ocul Immunol Inflamm | 2021 |
| 34955075 | Tattoo-Associated Uveitis. | Ocul Immunol Inflamm | 2021 |
| 35072584 | Ocular Toxocariasis. | Ocul Immunol Inflamm | 2021 |
| 35040720 | Vision Loss in Uveitis. | Ocul Immunol Inflamm | 2021 |
| 34675943 | Editorial: New Insights Into Uveitis: Immunity, Genes, and Microbes. | Front Immunol | 2021 |
| 34439078 | Vitreoretinal Lymphoma. | Cancers (Basel) | 2021 |
| 34596492 | SARS-CoV-2, COVID-19, and the Eye. | Ocul Immunol Inflamm | 2021 |
| 34559576 | Ocular Adverse Events After COVID-19 Vaccination. | Ocul Immunol Inflamm | 2021 |
| 34296968 | Intraocular Lymphoma. | Ocul Immunol Inflamm | 2021 |
| 34009095 | Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma. | Ocul Immunol Inflamm | 2021 |
| 33950774 | Genetics of Uveitis. | Ocul Immunol Inflamm | 2021 |
| 31714863 | Should We Reconsider the Classification of Patients with Dry Eye Disease? | Ocul Immunol Inflamm | 2021 |
| 33434090 | Tocilizumab for the Treatment of Ocular Inflammatory Disease. | Ocul Immunol Inflamm | 2021 |
| 33157077 | Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis. | Ophthalmology | 2021 |
| 32727731 | Standardisation of optical coherence tomography angiography nomenclature in uveitis: first survey results. | Br J Ophthalmol | 2021 |
| 32586933 | Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic. | Br J Ophthalmol | 2021 |
| 32469621 | Efficacy of Adalimumab in Non-Infectious Uveitis Across Different Etiologies: A Post Hoc Analysis of the VISUAL I and VISUAL II Trials. | Ocul Immunol Inflamm | 2021 |
| 32255398 | Efficacy of Topical Ivermectin for the Treatment of Cutaneous and Ocular Rosacea. | Ocul Immunol Inflamm | 2021 |
| 30986123 | Interferon Alpha for Refractory Pseudophakic Cystoid Macular Edema (Irvine-Gass Syndrome). | Ocul Immunol Inflamm | 2020 |
| 35921157 | Foreword from International Uveitis Study Group and Editor in Chief of Ocular Immunology and Inflammation. | Ocul Immunol Inflamm | 2020 |
| 32058830 | Medical Therapy of Uveitic Macular Edema: Biologic Agents. | Ocul Immunol Inflamm | 2020 |
| 31763952 | Tubercular Uveitis: Nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1. | Ocul Immunol Inflamm | 2020 |
| 32004111 | Inflammatory Choroidal Neovascularization. | Ocul Immunol Inflamm | 2020 |
| 32004112 | Editor's Introduction. | Ocul Immunol Inflamm | 2020 |
| 33200957 | The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 447 Patients with Tubercular Intermediate Uveitis and Panuveitis. | Ocul Immunol Inflamm | 2020 |
| 33196334 | Retinal Vasculitis. | Ocul Immunol Inflamm | 2020 |
| 32804578 | The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Descriptive Review of Tubercular Uveitis in Paediatric Population. | Ocul Immunol Inflamm | 2020 |
| 32997584 | HIV/AIDS and the Eye. | Ocul Immunol Inflamm | 2020 |
| 32600169 | Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6. | Ocul Immunol Inflamm | 2020 |
| 32600163 | The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients with Tubercular Anterior Uveitis. | Ocul Immunol Inflamm | 2020 |
| 32823392 | Viral anterior uveitis. | Indian J Ophthalmol | 2020 |
| 32797464 | [Evolving Consensus of International Uveitis Study Group, Intraocular Inflammation Society, and Foster Ocular Inflammation Society with Uveitis in the Time of COVID-19 Infection]. | Klin Monbl Augenheilkd | 2020 |
| 32589551 | Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis. | Ocul Immunol Inflamm | 2020 |
| 32870737 | Immune Checkpoint Inhibitor-Induced Uveitis. | Ocul Immunol Inflamm | 2020 |
| 32721206 | Evolving Consensus Experience of the IUSG-IOIS-FOIS with Uveitis in the Time of COVID-19 Infection. | Ocul Immunol Inflamm | 2020 |